A noted leader in hospital administration and medical affairs, Dr. Laura Forese has been appointed chief operating officer of NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Forese will continue to serve as chief medical officer and senior vice president at NewYork-Presbyterian/Weill Cornell, a position she has held since last year.

Thousands of men facing surgical removal of the prostate due to cancer may someday have one less thing to worry about: post-surgical urinary incontinence. That's because a team of expert urologic surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has devised a simple, effective means of reconstructing key anatomical structures that ensure continence.

Investment professional Gloria D. Reeg has been appointed Chief Investment Officer at NewYork-Presbyterian Hospital. In this position, she will oversee NewYork-Presbyterian's investment portfolio in order to help ensure the Hospital's continued ability to provide quality patient care, clinical research, medical education and community service.

For the first time, physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City have demonstrated in patients the ability of an antibody to directly target the blood supply of a wide variety of tumors, leaving healthy tissues unharmed.

Opening the doors to one of the first academic medical programs dedicated to surgical treatment of type 2 diabetes, NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created a new section of General Surgery called Gastrointestinal Metabolic Surgery. The program will be led by the newly appointed Dr. Francesco Rubino, a pioneering authority in the emerging specialty.

Of the nearly 1,500 spinal cord injuries (SCIs) sustained by children age 18 and younger every year, approximately 70 percent are a result of a motor vehicle accident. In 68 percent of those accidents, the child is not wearing a seatbelt. These findings, from one of the first studies to report on the incidence and causes of pediatric SCI, authored by physician-scientists at Morgan Stanley Children's Hospital of NewYork-Presbyterian and Columbia University Medical Center, and published in a recent issue of the Journal of Pediatric Orthopedics.

Scientists at Weill Cornell Medical College have identified a protein called Rab10 as an important partner in the insulin-mediated uptake of glucose by cells, opening the way to potential new drug targets for the prevention and treatment of type 2 diabetes.

Thousands of cardiac stent procedures are successfully performed every year, but a key challenge is positioning the stent, guidewires, and catheter at the precise location of the blockage. In addition, even with the most sophisticated X-ray technology, the complex shape of the heart and the twists and turns of the coronary arteries make the exact size of the blockage difficult to visualize and measure. As a result of these challenges, 10-20 percent of patients require a second stent due to inaccurate placement or size of the first stent.